178 related articles for article (PubMed ID: 21761347)
21. Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth.
Izzo F; Mercogliano F; Venturutti L; Tkach M; Inurrigarro G; Schillaci R; Cerchietti L; Elizalde PV; Proietti CJ
Breast Cancer Res; 2014 Dec; 16(6):491. PubMed ID: 25479686
[TBL] [Abstract][Full Text] [Related]
22. Liver kinase B1 expression (LKB1) is repressed by estrogen receptor alpha (ERα) in MCF-7 human breast cancer cells.
Linher-Melville K; Zantinge S; Singh G
Biochem Biophys Res Commun; 2012 Jan; 417(3):1063-8. PubMed ID: 22226967
[TBL] [Abstract][Full Text] [Related]
23. Expression of the human oestrogen receptor-alpha gene is regulated by promoter F in MG-63 osteoblastic cells.
Lambertini E; Penolazzi L; Giordano S; Del Senno L; Piva R
Biochem J; 2003 Jun; 372(Pt 3):831-9. PubMed ID: 12659635
[TBL] [Abstract][Full Text] [Related]
24. Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer.
Korobeynikov V; Borakove M; Feng Y; Wuest WM; Koval AB; Nikonova AS; Serebriiskii I; Chernoff J; Borges VF; Golemis EA; Shagisultanova E
Breast Cancer Res Treat; 2019 Sep; 177(2):369-382. PubMed ID: 31254157
[TBL] [Abstract][Full Text] [Related]
25. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function.
Jiang G; Wang X; Sheng D; Zhou L; Liu Y; Xu C; Liu S; Zhang J
Theranostics; 2019; 9(22):6501-6516. PubMed ID: 31588232
[TBL] [Abstract][Full Text] [Related]
26. Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferation.
Maruani DM; Spiegel TN; Harris EN; Shachter AS; Unger HA; Herrero-González S; Holz MK
Oncogene; 2012 Dec; 31(49):5073-80. PubMed ID: 22286763
[TBL] [Abstract][Full Text] [Related]
27. Involvement of a specificity proteins-binding element in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene.
Hockings JK; Degner SC; Morgan SS; Kemp MQ; Romagnolo DF
Breast Cancer Res; 2008; 10(2):R29. PubMed ID: 18377656
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of Aurora-A overrides estrogen-mediated growth and chemoresistance in breast cancer cells.
Lee HH; Zhu Y; Govindasamy KM; Gopalan G
Endocr Relat Cancer; 2008 Sep; 15(3):765-75. PubMed ID: 18469155
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
30. Unraveling the regulatory connections between two controllers of breast cancer cell fate.
Lee J; Tiwari A; Shum V; Mills GB; Mancini MA; Igoshin OA; Balázsi G
Nucleic Acids Res; 2014 Jun; 42(11):6839-49. PubMed ID: 24792166
[TBL] [Abstract][Full Text] [Related]
31. Regulation of estrogen receptor alpha gene mediated by promoter B responsible for its enhanced expressionin human breast cancer.
Tanimoto K; Eguchi H; Yoshida T; Hajiro-Nakanishi K; Hayashi S
Nucleic Acids Res; 1999 Feb; 27(3):903-9. PubMed ID: 9889290
[TBL] [Abstract][Full Text] [Related]
32. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
Liu Z; Shi HY; Nawaz Z; Zhang M
Cancer Lett; 2004 Jun; 209(1):55-65. PubMed ID: 15145521
[TBL] [Abstract][Full Text] [Related]
33. Bisphenol AF-induced endogenous transcription is mediated by ERα and ERK1/2 activation in human breast cancer cells.
Li M; Guo J; Gao W; Yu J; Han X; Zhang J; Shao B
PLoS One; 2014; 9(4):e94725. PubMed ID: 24727858
[TBL] [Abstract][Full Text] [Related]
34. Cell-cycle-dependent regulation of human aurora A transcription is mediated by periodic repression of E4TF1.
Tanaka M; Ueda A; Kanamori H; Ideguchi H; Yang J; Kitajima S; Ishigatsubo Y
J Biol Chem; 2002 Mar; 277(12):10719-26. PubMed ID: 11790771
[TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor alpha transcriptionally activates casein kinase 2 alpha: A pivotal regulator of promyelocytic leukaemia protein (PML) and AKT in oncogenesis.
Das N; Datta N; Chatterjee U; Ghosh MK
Cell Signal; 2016 Jun; 28(6):675-87. PubMed ID: 27012497
[TBL] [Abstract][Full Text] [Related]
36. Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis.
Romagnolo DF; Papoutsis AJ; Laukaitis C; Selmin OI
BMC Cancer; 2015 Dec; 15():1026. PubMed ID: 26715507
[TBL] [Abstract][Full Text] [Related]
37. Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.
Shackleford TJ; Zhang Q; Tian L; Vu TT; Korapati AL; Baumgartner AM; Le XF; Liao WS; Claret FX
Breast Cancer Res; 2011 Jun; 13(3):R65. PubMed ID: 21689417
[TBL] [Abstract][Full Text] [Related]
38. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
[TBL] [Abstract][Full Text] [Related]
39. Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.
Hao L; Rizzo P; Osipo C; Pannuti A; Wyatt D; Cheung LW; Sonenshein G; Osborne BA; Miele L
Oncogene; 2010 Jan; 29(2):201-13. PubMed ID: 19838210
[TBL] [Abstract][Full Text] [Related]
40. Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancer.
Treekitkarnmongkol W; Katayama H; Kai K; Sasai K; Jones JC; Wang J; Shen L; Sahin AA; Gagea M; Ueno NT; Creighton CJ; Sen S
Carcinogenesis; 2016 Dec; 37(12):1180-1189. PubMed ID: 27624071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
